- Home
- / Intensity Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Intensity Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.1
2024-10-29
Market Capitalization
$42.7 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 2.2M | 2.5M | 3.5M | 6.1M | 5.2M |
| Operating expense total | 8.0M | 7.6M | 8.3M | 16.6M | 12.0M |
| EBIT | (8.0M) | (7.6M) | (8.3M) | (16.6M) | (12.0M) |
| Interest income | 2.6K | 2.5K | 324.0K | 314.0K | 180.0K |
| Interest expense | 305.0K | ||||
| Net Income | (7.9M) | (7.6M) | (10.5M) | (16.3M) | (11.6M) |
| EPS | (2.3) | (2.2) | (1.4) | (1.2) | (8.6) |